Smith Graham & Co Investment Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $4.31M | Buy |
|
|||||
|
2023
Q2 | $5.24M | Buy |
|
|||||
|
2023
Q1 | $6.72M | Buy |
|
|||||
|
2022
Q4 | $6.76M | Sell |
|
|||||
|
2022
Q3 | $6.13M | Sell |
|
|||||
|
2022
Q2 | $10.3M | Sell |
|
|||||
|
2022
Q1 | $11.6M | Sell |
|
|||||
|
2021
Q4 | $12M | Sell |
|
|||||
|
2021
Q3 | $14.3M | Sell |
|
|||||
|
2021
Q2 | $11.9M | Sell |
|
|||||
|
2021
Q1 | $13.1M | Buy |
|
|||||
|
2020
Q4 | $8.59M | Sell |
|
|||||
|
2020
Q3 | $7.98M | Buy |
|
|||||
|
2020
Q2 | $7.61M | Buy |
|
|||||
|
2020
Q1 | $6.95M | Buy |
|
|||||
|
2019
Q4 | $8.41M | Sell |
|
|||||
|
2019
Q3 | $8.75M | Buy |
|
|||||
|
2019
Q2 | $8.56M | Buy |
|
|||||
|
2019
Q1 | $4.48M | Buy |
|